دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Mental health after China's prolonged lockdowns
doi : 10.1016/S0140-6736(22)01051-0
Volume 399, Issue 10342, 11 June 2022, Page 2167
COVID-19 mRNA vaccination and myocarditis or pericarditis
AndersHusbyaLarsKøberb
doi : 10.1016/S0140-6736(22)00842-X
Volume 399, Issue 10342, 11 June 2022, Pages 2168-2169
Head-to-head biologic therapy in Crohn's disease
Thomas PChapmanabJackSatsangia
doi : 10.1016/S0140-6736(22)00843-1
Volume 399, Issue 10342, 11 June 2022, Pages 2169-2171
Increasing children's global access to COVID-19 vaccines
ManishPatela MinalPatelb
doi : 10.1016/S0140-6736(22)00884-4
Volume 399, Issue 10342, 11 June 2022, Pages 2171-2173
Prevention of conflict-related sexual violence in Ukraine and globally
LindsayStarkaKim ThuySeelingeraReine-MarcellaIbalabYanaTovpekocDenisMukweged
doi : 10.1016/S0140-6736(22)00840-6
Volume 399, Issue 10342, 11 June 2022, Pages 2173-2175
Offline: Why science is not enough
RichardHorton
doi : 10.1016/S0140-6736(22)01048-0
Volume 399, Issue 10342, 11 June 2022, Page 2176
US infant formula crisis increases scrutiny of the FDA
SusanJaffe
doi : 10.1016/S0140-6736(22)01049-2
Volume 399, Issue 10342, 11 June 2022, Pages 2177-2178
Waiting for France's turn towards preventive health care
FerryBiedermann
doi : 10.1016/S0140-6736(22)01050-9
Volume 399, Issue 10342, 11 June 2022, Pages 2179-2180
Lola Kola: developing mHealth for mental health in west Africa
UdaniSamarasekera
doi : 10.1016/S0140-6736(22)01020-0
Volume 399, Issue 10342, 11 June 2022, Page 2181
Excavating and deciphering Tutankhamun
AndrewRobinson
doi : 10.1016/S0140-6736(22)01021-2
Volume 399, Issue 10342, 11 June 2022, Page 2182
Obstetric violence in historical perspective
ElizabethO’BrienaMiriamRichb
doi : 10.1016/S0140-6736(22)01022-4
Volume 399, Issue 10342, 11 June 2022, Pages 2183-2185
Arthur Dale Riggs
GeoffWatts
doi : 10.1016/S0140-6736(22)01023-6
Volume 399, Issue 10342, 11 June 2022, Page 2186
Preparing for what we abhor: an obligation of public health professionals
HenriqueLopesaJohnMiddletonbOliverRazumc
doi : 10.1016/S0140-6736(22)00889-3
Volume 399, Issue 10342, 11 June 2022, Page 2187
The value of oral care in dying and death
FrankLobbezooaGhizlaneAarabaMerel CVerhoeffaCatherine M CVolgenantb
doi : 10.1016/S0140-6736(22)00740-1
Volume 399, Issue 10342, 11 June 2022, Pages 2187-2188
The hijacking of science and truth by political conflict
Hélio AngottiNetoa
doi : 10.1016/S0140-6736(22)00919-9
Volume 399, Issue 10342, 11 June 2022, Page 2188
Opportunities for women's health in the first postnatal year
Jane EHirstabNicoleVotrubaabIan MBennettcJ JaimeMirandadePallab KMaulikef
doi : 10.1016/S0140-6736(22)00885-6
Volume 399, Issue 10342, 11 June 2022, Pages 2188-2189
Obesity definition for personalised treatment of type 2 diabetes
RajnaGolubicabThomas MBarbercRishiCaleyachettybc
doi : 10.1016/S0140-6736(22)00886-8
Volume 399, Issue 10342, 11 June 2022, Page 2189
Obesity definition for personalised treatment of type 2 diabetes  Authors’ reply
IldikoLingvayaPriyaSumithranbcRicardo VCohendCarel W leRouxef
doi : 10.1016/S0140-6736(22)00890-X
Volume 399, Issue 10342, 11 June 2022, Pages 2189-2190
Department of Error
doi : 10.1016/S0140-6736(22)00784-X
Volume 399, Issue 10342, 11 June 2022, Page 2190
Department of Error
doi : 10.1016/S0140-6736(22)01019-4
Volume 399, Issue 10342, 11 June 2022, Page 2190
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases
Hui-LeeWongPhDa*MaoHuBSb*Cindy KeZhouPhDaPatricia CLloydPhDaKandace LAmendPhDcDaniel CBeachlerPhDdAlexSecoraPhDeCheryl NMcMahill-WalravenPhDfYunLuPhDaYueWuMSbRachel POgilviePhDcChristianReichMDeDjeneba AudreyDjiboPhDfZhiruoWanMSbJohn DSeegerDrPHcSandiaAkhtarBSbYixinJiaoMPPbYoganandChillarigeMPAb…Steven AAndersonPhDa
doi : 10.1016/S0140-6736(22)00791-7
Volume 399, Issue 10342, 11 June 2022, Pages 2191-2199
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
ProfBruce ESandsMDaPeter MIrvingMDbcTimothyHoopsMDdJames LIzanecMDeLong-LongGaoPhDeChristopherGasinkMDeAndrewGreenspanMDeProfMatthieuAllezMDfProfSilvioDaneseMDgProfStephen BHanauerMDhProfVipulJairathMDijTanjaKuehbacherMDkProfJames DLewisMDlProfEdward VLoftusJrJr MDmEmeseMihalyMDnProfRemoPanaccioneMDoProfEllenScherlMDpOksana BShchukinaMDq…ZdenaZadorova
doi : 10.1016/S0140-6736(22)00688-2
Volume 399, Issue 10342, 11 June 2022, Pages 2200-2211
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
GraceLiMRCPCHa*FedericaCappucciniPhDab*Natalie GMarchevskyMSca*Parvinder KAleyPhDaRobertAleyBSc (Hons)aRachelAnslowBScaSagidaBibiPhDaKatrinaCathieMDcElizabethClutterbuckPhDaProfSaul NFaustFRCPCHcShuoFengPhDaProfPaul THeathFRCPCHdSimonKerridgeMScaAliceLelliottMRCPCHaYamaMujadidiMScaKhuen FoongNgMRCPCHeSarahRheadMRCPCHaHannahRobertsBSca…Bristol Clinical Research Nurse Team
doi : 10.1016/S0140-6736(22)00770-X
Volume 399, Issue 10342, 11 June 2022, Pages 2212-2225
The changing face of Klebsiella pneumoniae carbapenemase: in-vivo mutation in patient with chest infection
SiquanShenMScabQingyuShiPhDabProfFupinHuPhDab
doi : 10.1016/S0140-6736(22)01011-X
Volume 399, Issue 10342, 11 June 2022, Page 2226
Chronic obstructive pulmonary disease
Stephanie AChristensonMDaBenjamin MSmithMDbcProfMonaBafadhelPhDdeNirupamaPutchaMDf
doi : 10.1016/S0140-6736(22)00470-6
Volume 399, Issue 10342, 11 June 2022, Pages 2227-2242
